It has been hypothesized that hepatocyte growth factor (HGF) may play
an important role in regulating the growth of lung epithelium and in t
he regeneration of the lung as a paracrine or endocrine factor in idio
pathic pulmonary fibrosis (IPF). Based on this background, serum HGF w
as measured in 31 IPF patients (21 male/10 female, median age 60 years
). Fifteen age-matched normal non-smokers served as the control. Hepat
ocyte growth factor was measured by enzyme-linked immunosorbent assay
with monoclonal and polyclonal antibodies against human HGF (Otsuka As
say Laboratories, Tokushima, Japan). Elastase: alpha(1)-proteinase com
plex was also measured by enzyme-linked immunosorbent assay. No patien
ts had significant liver or renal dysfunction. As a result, mean (stan
dard error) serum HGF concentration of the patients with IPF was 0.384
(0.022) ng ml(-1), which was significantly high compared to normal no
n-smokers [0.213 (0.012) ng ml(-1), P<0.001, 95% confidence interval w
as between 0.104 and 0.238]. Serum HGF values correlated strongly with
the plasma elastase: alpha(1) proteinase inhibitor complex (R=0.679,
P<0.001). Immunohistochemical staining of lung tissue with anti-human
neutrophil elastase showed scattered immunopositive cells mainly in in
terstitium. Immunohistochemical staining with mouse anti-human HGF ant
ibody showed that HGF was distributed to the lung epithelial cells in
IPF lung specimens obtained by open lung biopsy. These results suggest
that HGF may play an important role in the pathogenesis of IPF.